Matches in SemOpenAlex for { <https://semopenalex.org/work/W2504583306> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2504583306 abstract "Therapeutic efficacy of epithelial growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is currently limited in selected lung cancer patients who have TKI sensitive EGFR mutation. However, the potential molecular mechanism that expands the therapeutic benefit of EGFT-TKI in patients who have wild-type EGFR non-small cell lung cancer (wtEGFR NSCLC) remains unclear. Recently, several studies revealed EGFR endocytosis mechanism could mediate signal transductions that influence in cancer cell proliferation. Moreover, our previous study demonstrated that EGFR endocytosis is related to gefitinib sensitivity in wtEGFR NSCLC and EGFR endocytosis could be a novel therapeutic target in lung cancer with wtEGFR (Oncotarget. 2014 15;5(5):1265-78). In this study, we investigated whether EGFR-TKI resistance could be restored in wtEGFR NSCLC cell lines by endocytosis inhibitor phenylarsine oxide (PAO). To investigate effects of PAO in vitro, we analyzed EGF-induced EGFR internalization and performed Annexin V and propodium iodide (PI) staining by flow cytometry. As a result, EGF-induced EGFR endocytosis is decreased and apoptotic cell death is induced accompanied by G0/G1 arrest after PAO treatment. In addition, we observed that cell viability is reduced significantly when PAO and EGFR-TKIs (gefitinib, erlotinib) treated together. Furthermore, we verified signaling transduction that associated with proliferation and apoptosis by western blot. To confirm combination effects of PAO and EGFR-TKI in vivo, we established xenograft mouse model using gefitinib-insensitive SNU1327 cell lines. After Tumor sizes reached 100-200mm 3 , mice were treated with PAO or gefitinib alone, or combined treatment for 3 weeks. We observed that tumor sizes of combination group were more decreased than other groups.In these result, we validate endocytosis inhibitor PAO is potential drug for overcoming therapeutic limitation of EGFR-TKI in gefitinib-insensitive wtEGFR NSCLC cell lines, though further experiment is needed to explain more accurate mechanism. This study was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2057538). Citation Format: Boyeon Kim, Jae Sook Sung, Yeul Hong Kim. Restoration of EGFR-TKI resistance by endocytosis inhibitor PAO in lung cancer with wild-type EGFR. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4680." @default.
- W2504583306 created "2016-08-23" @default.
- W2504583306 creator A5021336715 @default.
- W2504583306 creator A5068895221 @default.
- W2504583306 creator A5070638161 @default.
- W2504583306 date "2016-07-15" @default.
- W2504583306 modified "2023-09-27" @default.
- W2504583306 title "Abstract 4680: Restoration of EGFR-TKI resistance by endocytosis inhibitor PAO in lung cancer with wild-type EGFR" @default.
- W2504583306 doi "https://doi.org/10.1158/1538-7445.am2016-4680" @default.
- W2504583306 hasPublicationYear "2016" @default.
- W2504583306 type Work @default.
- W2504583306 sameAs 2504583306 @default.
- W2504583306 citedByCount "0" @default.
- W2504583306 crossrefType "proceedings-article" @default.
- W2504583306 hasAuthorship W2504583306A5021336715 @default.
- W2504583306 hasAuthorship W2504583306A5068895221 @default.
- W2504583306 hasAuthorship W2504583306A5070638161 @default.
- W2504583306 hasConcept C115456853 @default.
- W2504583306 hasConcept C121608353 @default.
- W2504583306 hasConcept C126322002 @default.
- W2504583306 hasConcept C142724271 @default.
- W2504583306 hasConcept C1491633281 @default.
- W2504583306 hasConcept C185592680 @default.
- W2504583306 hasConcept C190283241 @default.
- W2504583306 hasConcept C2776256026 @default.
- W2504583306 hasConcept C2778087573 @default.
- W2504583306 hasConcept C2778820342 @default.
- W2504583306 hasConcept C2779438470 @default.
- W2504583306 hasConcept C2780580887 @default.
- W2504583306 hasConcept C2781018059 @default.
- W2504583306 hasConcept C28005876 @default.
- W2504583306 hasConcept C29537977 @default.
- W2504583306 hasConcept C502942594 @default.
- W2504583306 hasConcept C55493867 @default.
- W2504583306 hasConcept C71924100 @default.
- W2504583306 hasConceptScore W2504583306C115456853 @default.
- W2504583306 hasConceptScore W2504583306C121608353 @default.
- W2504583306 hasConceptScore W2504583306C126322002 @default.
- W2504583306 hasConceptScore W2504583306C142724271 @default.
- W2504583306 hasConceptScore W2504583306C1491633281 @default.
- W2504583306 hasConceptScore W2504583306C185592680 @default.
- W2504583306 hasConceptScore W2504583306C190283241 @default.
- W2504583306 hasConceptScore W2504583306C2776256026 @default.
- W2504583306 hasConceptScore W2504583306C2778087573 @default.
- W2504583306 hasConceptScore W2504583306C2778820342 @default.
- W2504583306 hasConceptScore W2504583306C2779438470 @default.
- W2504583306 hasConceptScore W2504583306C2780580887 @default.
- W2504583306 hasConceptScore W2504583306C2781018059 @default.
- W2504583306 hasConceptScore W2504583306C28005876 @default.
- W2504583306 hasConceptScore W2504583306C29537977 @default.
- W2504583306 hasConceptScore W2504583306C502942594 @default.
- W2504583306 hasConceptScore W2504583306C55493867 @default.
- W2504583306 hasConceptScore W2504583306C71924100 @default.
- W2504583306 hasLocation W25045833061 @default.
- W2504583306 hasOpenAccess W2504583306 @default.
- W2504583306 hasPrimaryLocation W25045833061 @default.
- W2504583306 hasRelatedWork W1514762133 @default.
- W2504583306 hasRelatedWork W1965933252 @default.
- W2504583306 hasRelatedWork W1987321907 @default.
- W2504583306 hasRelatedWork W1998375723 @default.
- W2504583306 hasRelatedWork W2060723055 @default.
- W2504583306 hasRelatedWork W2080080809 @default.
- W2504583306 hasRelatedWork W2296687919 @default.
- W2504583306 hasRelatedWork W2317096894 @default.
- W2504583306 hasRelatedWork W2322434880 @default.
- W2504583306 hasRelatedWork W2343121555 @default.
- W2504583306 hasRelatedWork W2541433883 @default.
- W2504583306 hasRelatedWork W2741530549 @default.
- W2504583306 hasRelatedWork W2955020003 @default.
- W2504583306 hasRelatedWork W2969160463 @default.
- W2504583306 hasRelatedWork W2982141678 @default.
- W2504583306 hasRelatedWork W2982520973 @default.
- W2504583306 hasRelatedWork W3018250288 @default.
- W2504583306 hasRelatedWork W3024749488 @default.
- W2504583306 hasRelatedWork W3111721704 @default.
- W2504583306 hasRelatedWork W3177664578 @default.
- W2504583306 isParatext "false" @default.
- W2504583306 isRetracted "false" @default.
- W2504583306 magId "2504583306" @default.
- W2504583306 workType "article" @default.